"Neurocognitive Disorders" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Diagnoses of DEMENTIA and AMNESTIC DISORDER are subsumed here. (DSM-5)
| Descriptor ID |
D019965
|
| MeSH Number(s) |
F03.615
|
| Concept/Terms |
Neurocognitive Disorders- Neurocognitive Disorders
- Disorder, Neurocognitive
- Disorders, Neurocognitive
- Neurocognitive Disorder
|
Below are MeSH descriptors whose meaning is more general than "Neurocognitive Disorders".
Below are MeSH descriptors whose meaning is more specific than "Neurocognitive Disorders".
This graph shows the total number of publications written about "Neurocognitive Disorders" by people in this website by year, and whether "Neurocognitive Disorders" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2015 | 0 | 1 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 0 | 1 | 1 |
| 2019 | 2 | 0 | 2 |
| 2021 | 0 | 1 | 1 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neurocognitive Disorders" by people in Profiles.
-
Chaganti J, Gates TM, Brew BJ. Reversible large-scale network disruption correlates with neurocognitive improvement in HIV-associated minor neurocognitive disorder with combined anti-retroviral therapy intensification: a prospective longitudinal resting-state functional magnetic resonance imaging study. Neurol Sci. 2023 Sep; 44(9):3261-3269.
-
Chaganti J, Brew BJ. MR spectroscopy in HIV associated neurocognitive disorder in the era of cART: a review. AIDS Res Ther. 2021 10 09; 18(1):65.
-
Chaganti J, Marripudi K, Staub LP, Rae CD, Gates TM, Moffat KJ, Brew BJ. Imaging correlates of the blood-brain barrier disruption in HIV-associated neurocognitive disorder and therapeutic implications. AIDS. 2019 10 01; 33(12):1843-1852.
-
Meert KL, Guerguerian AM, Barbaro R, Slomine BS, Christensen JR, Berger J, Topjian A, Bembea M, Tabbutt S, Fink EL, Schwartz SM, Nadkarni VM, Telford R, Dean JM, Moler FW. Extracorporeal Cardiopulmonary Resuscitation: One-Year Survival and Neurobehavioral Outcome Among Infants and Children With In-Hospital Cardiac Arrest. Crit Care Med. 2019 03; 47(3):393-402.
-
Chaganti JR, Heinecke A, Gates TM, Moffat KJ, Brew BJ. Functional Connectivity in Virally Suppressed Patients with HIV-Associated Neurocognitive Disorder: A Resting-State Analysis. AJNR Am J Neuroradiol. 2017 Aug; 38(8):1623-1629.
-
Cichowitz C, Carroll PC, Strouse JJ, Haywood C, Lanzkron S. Utility of the Montreal Cognitive Assessment as a Screening Test for Neurocognitive Dysfunction in Adults with Sickle Cell Disease. South Med J. 2016 09; 109(9):560-5.
-
Lanzkron S, Haywood C. The five key things you need to know to manage adult patients with sickle cell disease. Hematology Am Soc Hematol Educ Program. 2015; 2015:420-5.
-
Orakcioglu B, Halatsch ME, Fortunati M, Unterberg A, Yonekawa Y. Intracranial dermoid cysts: variations of radiological and clinical features. Acta Neurochir (Wien). 2008 Dec; 150(12):1227-34; discussion 1234.
-
Kunkel EJ, Woods CM, Rodgers C, Myers RE. Consultations for 'maladaptive denial of illness' in patients with cancer: psychiatric disorders that result in noncompliance. Psychooncology. 1997 Jun; 6(2):139-49.
-
Zisselman M, Kim E, Rovner BW. Depression and anxiety in an 85-year-old woman with a toxic nodular goiter. Gen Hosp Psychiatry. 1995 Mar; 17(2):144-7.